Awiqli, the world's first weekly insulin, simplifies diabetes management by reducing daily injections while improving ...

A new once-weekly insulin option has arrived in India, offering a potential alternative to daily basal insulin injections for ...

Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side ...

A once-weekly insulin injection is an exciting development in diabetes care, but is it automatically better for everyone?

Novo Nordisk says Awiqli can cut basal insulin shots from 365 to 52 a year, targeting delayed insulin use in India’s vast ...

Novo Nordisk launched Awiqli, a once-weekly insulin, in India to treat type 1 and 2 diabetes. It aims to reduce injection ...

India has become one of the first countries in the world to introduce Awiqli, the world's first once-a-week basal insulin ...

The launch marks a major step in diabetes care, as patients who currently require one basal insulin injection every day may ...

Novo Nordisk has launched Awiqli, the world's first once-weekly basal insulin, in India for adults with Type 1 and Type 2 diabetes. The shift from daily to weekly injections could ease treatment ...

Novo Nordisk has introduced Awiqli (insulin icodec) in India, the world's first once-weekly basal insulin, reducing annual ...

Danish drugmaker Novo Nordisk has launched Awiqli, the world’s first once-weekly basal insulin, in India. Here’s how it works ...